Read more about China approves Sinopharm s new coronavirus vaccine for clinical trials on Business Standard. A new Covid-19 vaccine developed by China s Sinopharm has recently been approved for clinical trials.
CHINA / SOCIETY
By Xinhua Published: Apr 11, 2021 08:30 AM
People receive COVID-19 vaccine at a vaccination site in Gulou District of Nanjing, east China s Jiangsu Province, April 9, 2021.(Photo: Xinhua)
A new COVID-19 vaccine developed by China s Sinopharm has recently been approved for clinical trials.
The new recombinant COVID-19 vaccine, developed by the National Vaccine & Serum Institute, a R&D center of Sinopharm s bioscience subsidiary the China National Biotec Group (CNBG), got approval from the National Medical Products Administration on Friday, the CNBG said on its official Weibo account on Saturday.
The vaccine is based on the structural features of the receptor binding domain (RBD) on the virus spike protein (S-protein). It uses genetic engineering to grow harmless copies of the virus S-protein to induce neutralizing antibodies.
China approves new Covid vaccine for clinical trials prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.
China approves new COVID-19 vaccine for clinical trials - Life & Culture News sina.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com Daily Mail and Mail on Sunday newspapers.